Astrazeneca Plc ADR (AZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 11,390,000 | 12,011,000 | 9,866,000 | 8,220,000 | 7,320,000 |
| Cost of Goods | 3,511,000 | 4,625,000 | 3,757,000 | 2,191,000 | 1,864,000 |
| Gross Profit | 7,879,000 | 7,386,000 | 6,109,000 | 6,029,000 | 5,456,000 |
| Operating Expenses | 7,001,000 | 7,678,000 | 7,783,000 | 4,902,000 | 3,561,000 |
| Operating Income | 878,000 | -292,000 | -1,674,000 | 1,127,000 | 1,895,000 |
| Interest Expense | 336,000 | 336,000 | 335,000 | 326,000 | 303,000 |
| Other Income | 11,000 | -8,000 | 8,000 | -37,000 | 16,000 |
| Pre-tax Income | 553,000 | -636,000 | -2,001,000 | 764,000 | 1,608,000 |
| Income Tax | 165,000 | -290,000 | -350,000 | 214,000 | 46,000 |
| Net Income Continuous | 388,000 | -346,000 | -1,651,000 | 550,000 | 1,562,000 |
| Minority Interests | 2,000 | 1,000 | 1,000 | N/A | 1,000 |
| Net Income | $386,000 | $-347,000 | $-1,652,000 | $550,000 | $1,561,000 |
| EPS Basic Total Ops | 0.13 | -0.22 | -0.55 | 0.21 | 0.60 |
| EPS Basic Continuous Ops | 0.13 | -0.21 | -0.55 | 0.21 | 0.60 |
| EPS Diluted Total Ops | 0.13 | -0.22 | -0.55 | 0.21 | 0.60 |
| EPS Diluted Continuous Ops | 0.12 | -0.21 | -0.55 | 0.21 | 0.59 |
| EBITDA(a) | $2,187,000 | $1,900,000 | $1,114,000 | $1,880,000 | $2,692,000 |